RESTORATION OF NONCLONAL HEMATOPOIESIS IN CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA

被引:4
|
作者
EGERT, G [1 ]
KANZ, L [1 ]
LOHR, GW [1 ]
FAUSER, AA [1 ]
机构
[1] UNIV FREIBURG,SCH MED,MED KLIN,DEPT HEMATOL,HUGSTETTER STR 55,W-7800 FREIBURG,GERMANY
来源
BLUT | 1990年 / 60卷 / 05期
关键词
Chronic myelogenous leukemia; Philadelphia chromosome; Pluripotent stem cells; Recombinant interferon α;
D O I
10.1007/BF01736229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies have shown that recombinant human alpha interferon (rIFN α) inhibits the growth of colonies of multipotential stem cells from human bone marrow. This report demonstrates that rIFN α inhibits the growth of such colonies from the bone marrow of patients with chronic myelogenous leukemia (CML) to a greater extent than from bone marrow of healthy individuals. It also shows that T lymphocyte colonies subcloned with interleukin 2 (IL-2) from CML mixed colonies were inhibited more by rIFN α than were similar colonies subcultured from normal mixed colonies. The report demonstrates that the Ph' chromosome is present in such T cell colonies subcultured from CML mixed colonies. When mixed colonies were grown from CML bone marrow in the presence of rIFN α, Ph' negative colonies were observed, whereas no such Ph' negative mixed colonies grew from a similar number of bone marrow cells incubated without rIFN α. These observations confirm that T lymphocytes derived from bone marrow stem cells are from the CML clone, and that the inhibition of growth of Ph' positive colonies, by rIFN α permits the growth of residual normal stem cells. The disappearance of the Ph-chromosome in subclones of T lymphocytes supports the notion of nonclonal hematopoiesis in patients with CML. © 1990 Springer-Verlag.
引用
收藏
页码:282 / 286
页数:5
相关论文
共 50 条
  • [1] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA
    GUILHOT, F
    [J]. NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (02): : 200 - 201
  • [2] INTERFERON-ALPHA THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA
    WETZLER, M
    KANTARJIAN, H
    KURZROCK, R
    TALPAZ, M
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 99 (04): : 402 - 411
  • [3] INTERFERON-ALPHA FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
    THALER, J
    [J]. ACTA MEDICA AUSTRIACA, 1993, 20 (03) : 65 - 69
  • [4] Immunological effects of interferon-alpha on chronic myelogenous leukemia
    de Castro, FA
    Palma, PVB
    Morais, FR
    Simoes, BP
    Carvalho, PVB
    Ismael, SJ
    Lima, CP
    Voltarelli, JC
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (12) : 2061 - 2067
  • [5] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND INTERFERON-GAMMA
    KLOKE, O
    MAY, D
    WANDL, U
    BECHER, R
    OPALKA, B
    BEER, U
    NIEDERLE, N
    [J]. BLUT, 1990, 61 (01): : 45 - 46
  • [6] Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia
    Fava, S
    Luoni, M
    Stioui, S
    [J]. HAEMATOLOGICA, 1996, 81 (05) : 484 - 484
  • [7] INTERFERON-ALPHA IS AN ACTIVE THERAPEUTIC AGENT IN CHRONIC MYELOGENOUS LEUKEMIA
    KOYAMA, S
    SHIBATA, A
    [J]. ACTA HAEMATOLOGICA JAPONICA, 1990, 53 (08): : 1602 - 1610
  • [8] INTERSTITIAL PNEUMONIA CAUSED BY INTERFERON-ALPHA IN CHRONIC MYELOGENOUS LEUKEMIA
    YUFU, Y
    YAMASHITA, S
    NISHIMURA, J
    NAWATA, H
    HIRATA, J
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (03) : 253 - 253
  • [9] Interferon-alpha therapy for chronic myelogenous leukemia during pregnancy
    Kuroiwa, M
    Gondo, H
    Ashida, K
    Kamimura, T
    Miyamoto, T
    Niho, Y
    Tsukimori, K
    Nakano, H
    Ohga, S
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1998, 59 (01) : 101 - 102
  • [10] Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy
    Kantarjian, HM
    Giles, FJ
    O'Brien, SM
    Talpaz, M
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (01) : 31 - +